If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
479.40    1.40 (0.29%)
Bid:
481.20
Ask:
482.00
Spread: 0.80 (0.166%)
Market Cap: £2.46b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

$127m contract win in the US (formerly Avantus)

4 Oct 2023 07:00

RNS Number : 5923O
QinetiQ Group plc
04 October 2023
 

News release

QinetiQ Group plc

$127m contract win in the US (formerly Avantus)

 

4 October 2023 - QinetiQ Group plc (QinetiQ) is pleased to announce it has been awarded a five year $127m contract in the US from the Office of the Secretary of Defense Strategic Capabilities Office (SCO). QinetiQ will provide secure, technologically advanced services and products that will enable SCO to deploy new and enhanced capabilities in support of strategic operations.

This contract builds on our existing work and strong customer relationship with SCO, generating incremental growth on previous work. The contract will support our customers' mission to identify, analyse, and prototype disruptive applications of new systems, and implement emerging technologies to create operational effects that counter strategic adversaries. Following the $224m SDA contract award announced on 31 August 2023, this $127m SCO contract is a further demonstration of Avantus continuing to win significant programmes that underpin our target of greater than 10% annual revenue growth from Avantus.

Steve Wadey, Group Chief Executive Officer of QinetiQ, said:

"The award of this new contract is evidence of our US business continuing to deliver against our ambitious growth plan. The capabilities we acquired with Avantus last year are highly relevant to our customers and provide key services in support of their mission to solve some of the most complex national security challenges."

Investor Seminar: Key drivers of our global growth

QinetiQ will host an Investor Seminar on 25th October 2023 in New York, covering three of the key growth drivers for the company: our UK Intelligence business, Avantus and our wider US business, and our global threat representation capabilities. You are warmly invited to join in person or via live webcast.

To register to attend: https://www.qinetiq.com/en/investors/investor-seminars/key-drivers-of-our-global-growth

About QinetiQ

QinetiQ is an integrated global defence and security company focused on mission-led innovation. QinetiQ employs more than 8,000 highly-skilled people, committed to creating new ways of protecting what matters most; testing technologies, systems, and processes to make sure they meet operational needs; and enabling customers to deploy new and enhanced capabilities with the assurance they will deliver the performance required.

Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

For further information please contact:

John Haworth, Group Director Investor Relations:

+44 (0) 7920 545841

Lindsay Walls, Group Director Communications (Media enquiries):

+44 (0) 7793 427582

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTFFFSIIFLVIIV
Date   Source Headline
2nd Jul 20264:35 pmRNSDirector/PDMR Shareholding
2nd Jul 202612:02 pmRNSHolding(s) in Company
30th Jun 20262:07 pmRNSTotal Voting Rights
30th Jun 20267:00 amRNSTransaction in Own Shares
24th Jun 20263:30 pmRNSDirector/PDMR Shareholding
23rd Jun 20267:00 amRNSTransaction in Own Shares
17th Jun 20265:01 pmRNSHolding(s) in Company
16th Jun 20267:00 amRNSTransaction in Own Shares
10th Jun 20265:09 pmRNSDirector/PDMR Shareholding
10th Jun 202611:05 amRNSAnnual Financial Report
9th Jun 20265:00 pmRNSHolding(s) in Company
9th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20266:00 pmRNSHolding(s) in Company
2nd Jun 20267:00 amRNSTransaction in Own Shares
29th May 20264:45 pmRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSQinetiQ Full Year Results 2026
20th May 20264:16 pmRNSHolding(s) in Company
19th May 20264:00 pmRNSHolding(s) in Company
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20264:57 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20269:46 amRNSTransaction in Own Shares
30th Apr 20263:10 pmRNSTotal Voting Rights
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20261:38 pmRNSDirector Declaration
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 202612:00 pmRNSDirector/PDMR Shareholding
7th Apr 202610:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSDirector/PDMR Shareholding
31st Mar 20263:01 pmRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 202611:39 amRNSHolding(s) in Company
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 202612:30 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.